The Life Sciences Report: You manage your firm’s Sphera Global Healthcare Fund and are headquartered in Tel Aviv. How much exposure do you have to Israel?
Ori Hershkovitz: We have less than 1% exposure to Israel. We’re completely global.
TLSR: I want to talk about small- and mid-cap biotech stocks today, but when you appeared in a Bloomberg TV interview, you talked about Roche Holding AG (RHHBY:OTCQX). Do you follow large biopharmas as well as small … [visit site to read more]
Similar posts:- Look to Midtier and Small-Cap Gold Equities for Growth: Joe Foster The Gold Report: In the first decade of this century,...
- Junior Miners Still Giving the Street Something to Talk About: Philip Ker The Gold Report: Kitco reports that gold-specific exchange-traded products (ETPs)...
- Gold Equities Gaining Credibility: Doug Groh The Gold Report: Doug, macro factors like the European sovereign...
